close
close

Avalo Announces Participation in Investor Conferences in September

Posted on by Vaseline
Avalo Announces Participation in Investor Conferences in September

WAYNE, Pa. and ROCKVILLE, Md., Sept. 4, 2024 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Garry A. Neil, MD, Chief Executive Officer and Chairman of the Board, will present at two upcoming investor conferences:

HC Wainwright 26and Annual Global Investment Conference
Dates: September 9-11, 2024
A pre-recorded presentation will be made available on Monday, September 9, 2024 at 7:00 a.m. ET.

Related Posts